Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Antianginal agents with minimal arrhythmogenic potential developed at Lafon

Feb. 25, 2000

Paladin licenses Uniprost to United Therapeutics in Canada

Feb. 23, 2000

Gene therapy improves age-related cardiac disorder in rats

Feb. 23, 2000

New phenethylsulfones synthesized at Celgene useful for inflammation, etc.

Feb. 23, 2000

JTV-519 may provide cardioprotection by mimicking preconditioning

Feb. 22, 2000

Effective new antianginal agents under study at Lafon

Feb. 22, 2000

NicOx initiates French phase I trial of new oral formulation of NCX-4016

Feb. 22, 2000

NCBE inhibitors in development at Aventis

Feb. 21, 2000

High- vs. low-dose enalapril compared for immunological effects in CHF

Feb. 21, 2000

Adenosine A1 antagonists as alternatives to diuretics in CHF

Feb. 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...